P1.11.72 Phase II Study of Combination Azacitidine and Entinostat and Nivolumab in Patients With Metastatic Non-Small Cell Lung Cancer
20250 citationsJournal Article
Field-Weighted Citation Impact: 0.00
P1.11.72 Phase II Study of Combination Azacitidine and Entinostat and Nivolumab in Patients With Metastatic Non-Small Cell Lung Cancer | Researchclopedia